Cellular senescence, a major tumor-suppressive cell fate, has emerged from humble
beginnings as an in vitro phenomenon into recognition as a fundamental mechanism of …

Atherosclerotic cardiovascular disease (ASCVD) is a major cause of morbidity and mortality
in both men and women with T1DM and T2DM. In patients with T1DM, intensive glycemic …

There are currently eight different classes of drugs available for lowering cholesterol levels.
There are currently seven HMG-CoA reductase inhibitors (statins) approved for lowering …

Diabetes mellitus is a prevalent metabolic syndrome that is associated with high blood
glucose levels. The number of diabetic patients is increasing every year and the total …

Several medications and medication classes have been reported to affect the lipid profile.
Risk factors include elevated lipid levels at baseline and high cardiovascular (CV) risk …

The two major goals of the treatment of hypertriglyceridemia are the prevention of
cardiovascular disease and pancreatitis. Here we discuss the drugs used for the treatment of …

High blood glucose levels are a hallmark of the metabolic syndrome known as diabetes
mellitus. More than 600 million people will have diabetes by 2045 as the global prevalence …

Primary hyperlipidaemia in Schnauzer is characterized by increased plasma triglycerides
(TG) and/or total cholesterol (TC) concentration and is associated with an increased risk of …

Consumption of omega-3 fatty acids, including the precursor α-linolenic acid (ALA) is often
sub-optimal and not in line with international guidelines. Supplementation is debatable, but …

Atherosclerotic cardiovascular disease (ASCVD) is the primary contributor to global mortality
rates, which significantly escalates healthcare expenditures. Risk factors for ASCVD …